Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sivan Gazit

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Viruses|September 28, 2023
BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination CampaignAmir Ben-Tov, Benjamin Lebwohl, Tamar Banon, et al.
Journal of Clinical Medicine|February 27, 2026
Triptan Use and Potential Undertreatment in Migraine: A Retrospective Cohort StudyYael Barer, Moshe Hoshen, Sivan Gazit, et al.
Virology Journal|August 7, 2025
Epidemiology of hepatitis delta virus (HDV) infection and comparison of clinical characteristics and disease progression among patients with HDV vs. hepatitis B mono-infection: real-world data from a large healthcare insurer-provider in IsraelRawi Hazzan, Clara Weil, Marvin Rock, et al.
Science (New York, N.Y.)|January 27, 2022
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in IsraelOttavia Prunas, Joshua L Warren, Forrest W Crawford, et al.
Inflammatory Bowel Diseases|October 15, 2025
Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort StudyHenit Yanai, Tomer Achler, Amir Ben-Tov, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in IsraelOttavia Prunas, Joshua L Warren, Forrest W Crawford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of Coronavirus Disease 2019 PatientsSivan Gazit, Barak Mizrahi, Nir Kalkstein, et al.
Scandinavian Journal of Primary Health Care|October 31, 2022
Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort StudyLimor Adler, Sivan Gazit, Yuval Pinto, et al.
Nature Communications|March 5, 2022
Waning of SARS-CoV-2 booster viral-load reduction effectivenessMatan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.
Vaccine|May 18, 2026
Corrigendum to "A significant decrease in anogenital warts incidence following the implementation of a national human papillomavirus immunization program in Israel" [Vaccine 80 (2029) 128516]Ilona Shapiro, Bekana K Tadese, Moshe Hoshen, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Viruses|September 28, 2023
BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination CampaignAmir Ben-Tov, Benjamin Lebwohl, Tamar Banon, et al.
Journal of Clinical Medicine|February 27, 2026
Triptan Use and Potential Undertreatment in Migraine: A Retrospective Cohort StudyYael Barer, Moshe Hoshen, Sivan Gazit, et al.
Virology Journal|August 7, 2025
Epidemiology of hepatitis delta virus (HDV) infection and comparison of clinical characteristics and disease progression among patients with HDV vs. hepatitis B mono-infection: real-world data from a large healthcare insurer-provider in IsraelRawi Hazzan, Clara Weil, Marvin Rock, et al.
Science (New York, N.Y.)|January 27, 2022
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in IsraelOttavia Prunas, Joshua L Warren, Forrest W Crawford, et al.
Inflammatory Bowel Diseases|October 15, 2025
Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort StudyHenit Yanai, Tomer Achler, Amir Ben-Tov, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in IsraelOttavia Prunas, Joshua L Warren, Forrest W Crawford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of Coronavirus Disease 2019 PatientsSivan Gazit, Barak Mizrahi, Nir Kalkstein, et al.
Scandinavian Journal of Primary Health Care|October 31, 2022
Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort StudyLimor Adler, Sivan Gazit, Yuval Pinto, et al.
Nature Communications|March 5, 2022
Waning of SARS-CoV-2 booster viral-load reduction effectivenessMatan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.
Vaccine|May 18, 2026
Corrigendum to "A significant decrease in anogenital warts incidence following the implementation of a national human papillomavirus immunization program in Israel" [Vaccine 80 (2029) 128516]Ilona Shapiro, Bekana K Tadese, Moshe Hoshen, et al.
Pageof 8